Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

SAC minutes

Summary of Scientific Advisory Committee meetings

Final periodic report to the EC

Final periodic report to the EC, containing deliverables

Budget templates

Budget templates for awardees to complete

List of communication activities conducted, period 2

List of main communication activities conducted, period 2

List of communication activities conducted, period 4

List of main communication activities conducted, period 4

Project description template

CEPI's project description template for awardees

List of communication activities conducted, period 3

List of main communication activities conducted period 3

3rd periodic report to the EC

3rd periodic report to the EC containing deliverables

2nd periodic report to the EC

2nd periodic report to the EC , containing deliverables for given period

Opening of call online

Validation of the call being opened and made public

Call text

Call text published on the internet provided to the EC

Publicaciones

Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes

Autores: Corey L. Campbell, Trey K. Snell, Susi Bennett, John H. Wyckoff III, Darragh Heaslip, Jordan Flatt, Emma K. Harris, Daniel A. Hartman, Elena Lian, Brian H. Bird, Mark D. Stenglein, Richard A. Bowen, Rebekah C. Kading
Publicado en: WILEY ONLINE LIBRARY, Edición Volume 69, Edición 5, 2022, Página(s) Pages 2621-2633, ISSN 0000-0000
Editor: WILEY ONLINE LIBRARY
DOI: 10.1111/tbed.14415

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera

Autores: Pierre Roques, Andrea Fritzer, Nathalie Dereuddre-Bosquet, Nina Wressnigg, Romana Hochreiter, Laetitia Bossevot, Quentin Pascal, Fabienne Guehenneux, Annegret Bitzer, Irena Corbic Ramljak, Roger Le Grand, Urban Lundberg, Andreas Meinke
Publicado en: JCI Insight, Edición Volume 7, Edición14, 2022, ISSN 2379-3708
Editor: JCI Insight
DOI: 10.1172/jci.insight.160173

Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset

Autores: Wichgers Schreur PJ, Mooij P, Koopman G, Verstrepen BE, Fagrouch Z, Mortier D, van Driel N, Kant J, van de Water S, Bogers WM, Punt C, van Keulen L, Verschoor EJ, Kortekaas J.
Publicado en: NPJ Vaccines, 2022, ISSN 2059-0105
Editor: NPJ Vaccines
DOI: 10.1038/s41541-022-00476-y

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo

Autores: Watson-Jones D, Kavunga-Membo H, Grais RF, Ahuka S, Roberts N, Edmunds WJ, Choi EM, Roberts CH, Edwards T, Camacho A, Lees S, Leyssen M, Spiessens B, Luhn K, Douoguih M, Hatchett R, Bausch DG, Muyembe JJ.
Publicado en: BMJ Open, Edición 2022, 2022, Página(s) 12, ISSN 2044-6055
Editor: BMJ Publishing Group
DOI: 10.1136/bmjopen-2021-055596

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Autores: Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl, Andrea Fritzer, Nicole Bézay, Anton Klingler, Karen Lingnau, Martina Schneider, Urban Lundberg, Andreas Meinke, Julian Larcher-Senn, Irena Čorbic-Ramljak, Susanne Eder-Lingelbach, Katrin Dubischar, Wolfgang Bender.
Publicado en: The Lancet, Edición Volume 20, Edición 10, 2020, ISSN 0140-6736
Editor: The Lancet Publishing Group
DOI: 10.1016/s1473-3099(20)30238-3

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Autores: Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl, Robert McMahon, Sebastian Toepfer, Ulrike Fuchs, Romana Hochreiter, Annegret Bitzer, Karin Kosulin, Julian Larcher-Senn, Robert Mader, Katrin Dubischar, Oliver Zoihsl, Juan-Carlos Jaramillo, Susanne Eder-Lingelbach, Vera Buerger, Nina Wressnigg.
Publicado en: The Lancet, Edición VOLUME 401, ISSUE 10394, 2023, ISSN 0140-6736
Editor: The Lancet Publishing Group
DOI: 10.1016/s0140-6736(23)00641-4

Buscando datos de OpenAIRE...

Se ha producido un error en la búsqueda de datos de OpenAIRE

No hay resultados disponibles